TrialBritish journal of clinical pharmacology2026
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma.
Anna Lundahl et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papertrialcites it